Resistance to β-lactam antibiotics
K Poole - Cellular and Molecular Life Sciences CMLS, 2004 - Springer
Abstract β-lactams have a long history in the treatment of infectious diseases, though their
use has been and continues to be confounded by the development of resistance in target …
use has been and continues to be confounded by the development of resistance in target …
Antimicrobial resistance of Escherichia coli and therapeutic implications
H Von Baum, R Marre - International Journal of Medical Microbiology, 2005 - Elsevier
Widespread antibiotic resistance has been recognized in Escherichia coli isolates from
human, animal and environmental sources. Although prevalence rates for resistant E. coli …
human, animal and environmental sources. Although prevalence rates for resistant E. coli …
Explaining adherence success in sub-Saharan Africa: an ethnographic study
Background Individuals living with HIV/AIDS in sub-Saharan Africa generally take more than
90% of prescribed doses of antiretroviral therapy (ART). This number exceeds the levels of …
90% of prescribed doses of antiretroviral therapy (ART). This number exceeds the levels of …
Colistin-resistant isolates of Klebsiella pneumoniae emerging in intensive care unit patients: first report of a multiclonal cluster
A Antoniadou, F Kontopidou, G Poulakou… - Journal of …, 2007 - academic.oup.com
Objectives Infections due to multidrug-resistant (MDR) Gram-negative pathogens in the ICU
have prompted the use of colistin, an antibiotic forgotten for decades. The aim of this …
have prompted the use of colistin, an antibiotic forgotten for decades. The aim of this …
Detection of Extended-Spectrum Beta-Lactamases among Enterobacteriaceae by Use of Semiautomated Microbiology Systems and Manual Detection Procedures
I Wiegand, HK Geiss, D Mack… - Journal of clinical …, 2007 - Am Soc Microbiol
Three commercially available microbiology identification and susceptibility testing systems
were compared with regard to their ability to detect extended-spectrum β-lactamase (ESBL) …
were compared with regard to their ability to detect extended-spectrum β-lactamase (ESBL) …
Characterization of CTX-M enzymes, quinolone resistance determinants, and antimicrobial residues from hospital sewage, wastewater treatment plant, and river water
D Conte, JK Palmeiro, K da Silva Nogueira… - Ecotoxicology and …, 2017 - Elsevier
Multidrug-resistant (MDR) bacteria are widespread in hospitals and have been increasingly
isolated from aquatic environments. The aim of the present study was to characterize …
isolated from aquatic environments. The aim of the present study was to characterize …
Emergence of carbapenem-non-susceptible extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolates at the university hospital of Tübingen …
S Gröbner, D Linke, W Schütz… - Journal of medical …, 2009 - microbiologyresearch.org
The spread of Gram-negative bacteria with plasmid-borne extended-spectrum β-lactamases
(ESBLs) has become a worldwide problem. This study analysed a total of 366 ESBL …
(ESBLs) has become a worldwide problem. This study analysed a total of 366 ESBL …
Fosfomycin in the treatment of extended spectrum beta-lactamase-producing Escherichia coli-related lower urinary tract infections
H Pullukcu, M Tasbakan, OR Sipahi… - International journal of …, 2007 - Elsevier
Fosfomycin tromethamine (FT) is effective in vitro in extended spectrum beta-lactamase
(ESBL)-producing Escherichia coli strains. The aim of this study was to evaluate the effect of …
(ESBL)-producing Escherichia coli strains. The aim of this study was to evaluate the effect of …
In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: the 2003 Study for Monitoring …
Abstract Objectives: The SMART (Study for Monitoring Antimicrobial Resistance Trends)
surveillance programme was begun in 2002 to monitor antimicrobial resistance trends …
surveillance programme was begun in 2002 to monitor antimicrobial resistance trends …
Ampicillin/sulbactam: current status in severe bacterial infections
PI Rafailidis, EN Ioannidou, ME Falagas - Drugs, 2007 - Springer
Ampicillin/sulbactam is a β-lactam/β-lactamase inhibitor combination with a broad spectrum
of antibacterial activity against Gram-positive, Gram-negative and anaerobic bacteria. Data …
of antibacterial activity against Gram-positive, Gram-negative and anaerobic bacteria. Data …